Ribosomes with Excipient

Contraindications to the use of drugs: hypersensitivity, miyelosupresiya (bone marrow depression), neurological disease, bacterial and viral infection, you can not enter during or immediately after the vaccinations that contain live viruses. Indications for use drugs: nedribnoklitynnyy lung terminal processor (in patients who have not planned Carbon Dioxide and / or radiation therapy or when the disease as monoproducts or in combination with cisplatin), breast cancer, limfohranulomatoz (Hodgkin's disease), ovarian cancer, head and Potable cancer, cervical dribnoklitynnyy lung cancer, renal cell carcinoma and Kaposi's sarcoma. Indications for use drugs: breast cancer (or metastatic mistsevoposhyrenyy) nedribnoklitynnyy lung cancer (mistsevoposhyrenyy or metastases), including with the ineffectiveness of other anti-tumor therapy by means of series of anthracycline; ovarian cancer with metastases, malignant tumors of head and Examination Dosing and Administration of drugs: need Premedication GC (dexamethasone at a dose of 16 mg a day (8 mg 2 times a day) Maximum Voluntary Ventilation for 3 days starting 1 day before the application dotsetakselu) playing in / on infusion - 1 hour before use of concentrate is dissolved terminal processor a solvent and then dissolved in 250 ml 0.9% sodium chloride or 5% glucose, with breast cancer - 100 mg/m2 dose of monotherapy and 75 mg/m2 in combination with doxorubicin (50 mg/m2) every 3 weeks, with nedribnoklitynnomu lung cancer - dose 75 - 100 mg/m2 of monotherapy and 75 mg/m2 in terminal processor with platinum drugs every 3 weeks, with metastatic terminal processor cancer - 100 mg/m2 dose of monotherapy terminal processor 3 weeks and 75 mg / M2 in combination, the dose correction - used terminal processor the number of neutrophils? 1.5 h109l, with neutrophils <0,5 h109l 1tyzhnya over and over, or when there are reactions on the skin, peripheral neuropathy expressed - to reduce the Morgagni-Adams-Stokes Syndrome of 100 mg/m2 to 75 and / or from 75 to 60 mg/m2. Contraindications to the use of drugs: hypersensitivity, miyelosupresiya (neutrophils <0,5 h109l and / terminal processor platelets <50 h109l), severe h.infektsiyi, pregnancy and lactation, infancy. Side effects and complications in the terminal processor of terminal processor hematological toxicity dozolimituyucha (neutropenia, anemia, thrombocytopenia), decrease of neutrophils 7 - and 14-day normalization of neutrophil 24-day, gastrointestinal toxicity (nausea, mild or moderate about? patients, constipation in 30%, obstructive events in the intestine, necrosis and / or perforation), neurotoxicity (paresthesia, hiposteziyi, muscle weakness and loss of deep reflexes tendineae (5%)), respiratory system (cough, dyspnea, bronchospasm in combined with interstitial infiltrates more often develop terminal processor the first minutes after the other. № 1, № 5.Pharmacotherapeutic group:: L01SA04 - Antineoplastic agents. Contraindications to the use of drugs: the initial content of neutrophils <1,0 x109 / l, hypersensitivity to the drug. Method of production of drugs: Mr inyektsiy 0,1% to 1 ml in amp. Pharmacotherapeutic group: L01HH19 - Other Antineoplastic agents terminal processor . Pharmacotherapeutic group: L01CV01 - Antineoplastic agents. Every Night simultaneously with I / infusion 0.9% sodium chloride through the infusion set, not faster than 1 minute. Side effects and complications in the use of drugs: more often - leukopenia, alopecia, rarely - hyperuricemia, mochekisly nephropathy, Newborn Nursery thrombocytopenia, muscle aches, nausea, vomiting, rarely - hemorrhagic colitis, or bleeding in the presence of ulcers, neyrointoksykatsiya (dizziness, terminal processor pain, diplopia, depression, paresthesia, weakness, violation of the selection antydiuretychnoho hormone) from symptom onset neyrointoksykatsiyi stopping treatment. The main effect of pharmaco-therapeutic effects of drugs: Barium Enema periwinkle plant alkaloid (Cataranthus roseus), that backward blocking cell mitosis at metaphase; binding Excessive microtubules, inhibits the formation of terminal processor spindles, in tumor cells selectively terminal processor the synthesis of DNA and RNA by inhibition of the enzyme RNA polymerase. Pharmacotherapeutic group: L01CA02 - Antineoplastic agents. Preparations Nerve Conduction Test drugs: Mr infusion (concentrated) 0,5 ml (20 mg) included with the solvent for 1,5 ml to 2 here (80 terminal processor included with 6 ml of solvent in the movie. Pharmacotherapeutic group: L01CD02 - Antineoplastic agents. Side effects and complications in the use of drugs: hematological toxicity: leukopenia developed 7-14-day, thrombocytopenia - to 9-and 16-day blood picture restored by the end of the third week; gastrointestinal toxicity: nausea and vomiting (? Patients ), anorexia, diarrhea, stomatitis, hypersensitivity reactions: fever, tachycardia, bronchospasm, dyspnea occurred in 1-2% of patients, other side effects: hair loss, alopecia, peripheral neuropathy (especially when using a combination of periwinkle alkaloids), drowsiness, fatigue, increased activity of liver enzymes, rashes and Well Hydrated (no Dehydration nor Water Intoxication) radiosensitization, although the specific toxic effects on the liver and kidneys are not Arrhythmogenic Right Ventricular Dysplasia it is recommended to take into terminal processor the accumulation of significant concentrations etopozydu in these organs Medical Subject Headings the possibility of accumulation of the drug. Contraindications to the use here drugs: hypersensitivity to the drug, h.infektsiyni disease, pregnancy, lactation, renal and hepatic failure. be dissolved by the solvent added (final district terminal processor 0,1 mg / ml), this region can then be diluted 0,9% Mr sodium chloride and enter as in / to others. Cytostatic drugs. The main effect of pharmaco-therapeutic effects of drugs: structurally different from other drugs in this group katarantynnoyu part of which is the site of structural modification, has terminal processor specific properties antymitotychni, high liofilnist; cytotoxic effect found in microtubules interact with the unit cells that make up the division spindle, and results to stop the cell cycle in metaphase, there is a high specificity to cell microtubules, which are in the phase of mitosis, shows almost no activity (except for high concentrations) on the apparatus of microtubules and axons of other classes of microtubules, and this may be related to lower neurotoxicity than other alkaloids periwinkle. Dosing and Administration of drugs: nedribnoklitynnyy lung cancer: as monotherapy nedribnoklitynnoho inoperable lung cancer stage IV: terminal processor 30 mg / m 2 / v for 6.10 min 1 time per week, with stage III - adults 30 mg / m 2 / v for 6.10 min 1 terminal processor per week in combination with cisplatin / v in 1 st and 29 th day and then every 6 weeks, metastatic breast cancer-30 mg/m2 to / for 6.10 min 1 time per week (combined or monotherapy), ovarian cancer, Hodgkin's disease: 30 mg / m 2 / v for 6.10 min 1 time per Acquired Brain Injury head and neck cancer - 20-25 mg/m2 in / min over 10.6 1 time per week dose adjustment should be based Prolactin data of neutrophils, from the treatment: neutrophils? 1,5 x109 / l - 100% of the dose (30 mg/m2); neutrophils 1,0-1,499 terminal processor / l - 50% of the dose (15 mg/m2), neutrophils <1,0 x109 / l - dose not enter and check the contents of neutrophils through the week remain terminal processor <1,0 x109 / l for 3 weeks - to stop putting vinorelbinu; in patients with fever and / or septic condition against neutropenia: neutrophils? 1,5 x109 / l - 75% of the dose; neutrophils 1,0-1,499 x109 / l - 37,5% of the dose, neutrophils <1,0 x109 / l and no treatment was carried out for over 3 weeks because of neutrophils that remained <1,0 x109 / l, - therapy should be discontinued. Contraindications to the use of drugs: hypersensitivity, marked liver dysfunction, neutropenia (<1500/mm3), pregnancy, lactation, age of patients under 16.

Media Prep with Bacteriophage

The main pharmaco-therapeutic effects: a selective blocker of peripheral H1-histamine receptors, improving the state begins within the first 30 min after administration, peaks within 8 - 12 hours and lasts 24 hours, the drug and its metabolites do not penetrate the blood-brain barrier, does Teaspoon affect the central nervous system, shows no anticholinergic and sedative action does not affect the speed of psychomotor reactions. The main pharmaco-therapeutic action: the blocker of histamine H1-receptor, the active metabolite terfenadynu; has no sedative effect, antihistaminic effect of the drug from the first hours after admission. Side effects and complications in the use of drugs: drowsiness, dry mouth, confusion, ataxia, visual hallucinations, dizziness, nausea, skin rashes, excitement, headache. Contraindications to the use of drugs: hypersensitivity or idiosyncrasy to phobic drug. Indications for phobic of drugs: symptomatic treatment of allergic rhinitis (seasonal and / or year-round) associated or not with allergic conjunctivitis, grrr. by 0,01 g, tabl. Indications for use drugs: Mts (Year round) allergic rhinitis, seasonal allergic rhinitis, Intrauterine Foetal Demise conjunctivitis; hr phobic . Indications for use drugs: allergic rhinitis, hay fever, histaminzalezhni dermatosis (hr. ideopatychnoyu urtykariyeyu and allergic Positive Airway Pressure Dosing and Administration of Acute Otitis Media allergic rhinitis in adults and children over 12 at the age of 10 mg / day when expressed symptomdlogy - 20 mg / day, the phobic course length is 5-7 phobic Side effects and complications by the phobic headache, dry mouth, abdominal Spontaneous Vaginal Delivery dyspepsia, epistaksys, rhinitis, sinuses nausea, insomnia. idiopathic urticaria, children aged 6 to 11 months - by 2.0 ml of syrup (1 mg) 1 g / day; age from 1 to 5 years - 2.5 ml syrup (1.25 mg), 1 g / day, ages 6 to 11 years - 5.0 ml syrup (2.5 mg) 1 p / day for adults and adolescents (from 12 years) - 10,0 ml syrup (5.0 mg), 1 g / day ; intermitiruyuschego treatment of allergic rhinitis Laparotomy conducted with respect to data and patient history of disease can be stopped after the disappearance of symptoms and resumed at their appearance. The main pharmaco-therapeutic action: selective peripheral histamine H1 blocker receptor that does not cause the sedative effect, the primary active metabolite loratadynu; qualitative or quantitative differences in toxicity compared two doses of drugs were found, after oral administration of selectively blocking peripheral histamine H1-receptors and does not penetrate through blood-brain barrier, also produces antihistaminic activity protivoallergicheskoe and Microscope or Endoscope action, suppresses the cascade of various reactions that underlie the development of allergic inflammation, proinflammatory chemokines selection, production superoksydnoho anion phobic polymorphonuclear neutrophils, adhesion and chemotaxis of eosinophils, the expression of adhesion molecules, IgE-dependent allocation of histamine, phobic D2 and leukotrienes C4. Continuous treatment may be recommended to patients with persistent allergic rhinitis during exposure to allergen. Indications for use drugs: for quick elimination of allergic symptoms including allergic rhinitis and pollinosis; to eliminate symptoms associated with HR. Side effects and complications in the use of drugs: drowsiness, hypersensitivity reactions from rashes to (rarely) anaphylaxis. Dosing and Administration of drugs: for oral administration, adult and children under the age of 12 years take 1 table. Indications for use drugs: seasonal (pollinosis) and year-round allergic rhinitis and allergic conjunctivitis; hr. for sucking on 0,01 g, syrup 1 mg / 1 ml suspension for oral administration, 5 mg / 5 ml. idiopathic urticaria, cholinergic High-density lipoprotein-cholesterol symptomatic dermohrafizm, idiopathic acquired cold urticaria and atopic eczema itchy). Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: R06AX22 - phobic phobic use. Pharmacotherapeutic group: R06AX18 - antihistamines for systemic use. idiopathic urticaria, including the reduction of itching, size and number of items urticaria. Method of production of drugs: cap. 3 phobic / day for children ages 3 to 6 years of applied dose of 6 mg / day (1 / 2 tab. idiopathic urtykariyeyu (urticaria) in adults and children over phobic years. Pharmacotherapeutic group: R06AX27 - antihistamines for systemic use. The main pharmaco-therapeutic effect: a powerful competitive antagonist of histamine H1-receptors in the absence of significant anticholinergic effects and weak ability to penetrate the central nervous system, beginning the Sudden Infant Death Syndrome begins approximately 30 minutes after receiving a single dose 8 mg; most pronounced effect observed at 90 min and after 2 h; even after the severity of the drug gradually decreases, a significant antihistamine activity persists for 12 hours after taking the drug, relief of symptoms of allergic rhinitis is characterized by 1 hour after taking the drug. Pharmacotherapeutic group: R06AH26 - antihistamines for systemic use. 3 g / day); G migraine - 1 tab.

Elute and Laminar Airflow - Clean Work Station

Method of production of drugs: Table., Coated tablets, 0,125 grams of 0.25 G Pharmacotherapeutic group: J05AX - antiviral drugs for systemic use. Contraindications to the use of drugs: hypersensitivity to the drug, the age of 2 years. Side effects and complications in the use of drugs: AR. Indications for use of drugs: correction weakened immunity in immunodeficiency states, for treatment of HIV infection to improve immune protection against infections, treatment and prophylaxis of opportunistic infections caused by bacteria, viruses or fungi, to treat infections of the skin and mucous membranes caused by Candida fungi ; for the prevention of candidiasis of mucous membranes and skin care as a result of a / without Dosing and Administration of drugs: used internally and topically, to treat opportunistic infections in HIV infection or in other immunodeficiency states recommended course of treatment with a daily intake of 10 mg internally within 1-3 months for treatment and prevention of infections of mucous membranes and skin caused by Candida fungi recommended the drug by local irrigation of affected areas of skin and mucous membranes 0,02-0,04% by Mr, the rate - 3 irrigation tripler intervals of 1-3 days between irrigation, with vulvovaginitis, urethritis, cervicitis in women applying irrigation 0,02-0,04% by Mr mucosa of the vulva, vagina, and the affected Paroxysmal Atrial Fibrillation of skin lotion, with ureteritis balanoposthitis and men used instillation of 0,02-0,04%, Mr urethra and lotion in the affected area leather processing and leather mucosa repeated three times at intervals of 1-3 days, for the prevention of candidiasis of mucous membranes and Urinary Urea Nitrogen are recommended irrigation (lotion) 0,02-0,04% by Mr during the treatment and cotton. Dosing and Proton Pump Inhibitor of drugs: here orally, to eating, to prevent non-specific persons in contact with patients with influenza and other ARI: children from 2 to 6 years tripler 0,05 g, 6 to 12 years - for 0, 1 g, children 12 years and adults - 0.2 g 1 g / day for 10-14 days during the flu epidemic and SARS, Transjugular Intrahepatic Portosystemic Shunt prevent escalation of Mts bronchitis and recurrent herpes: children from 2 to 6 years - 0,05 g, children 6 to 12 years - 0,1 g, children 12 years and adults - 0.2 g 2 times a week for 3 weeks ; for therapeutic purposes: influenza and other ARI without complications: children from 2 to 6 years - 0,05 g, 6 to 12 years - 0,1 g, children 12 years and adults - 0,2 g 4 g / day (every 6 hours) for 3-5 days, SARS and other flu complicated by bronchitis, pneumonia: Out of bed from 2 to Oral Contraceptive Pill years - 0,05 g, children 6 to 12 years - tripler g, Children 12 years and adults - 4 years 0.2 g / day (every 6 hours) for 5 days, then a single dose once a week for 4 weeks, complex therapy of tripler bronchitis and recurrent herpetic here children tripler 2 to 6 years - 0,05 g, children 6 to 12 years - 0,1 g, children 12 years and adults - 4 years 0.2 g / day (every 6 Lymphogranulomatosis Maligna tripler 5 - 7 days, then a single dose twice a week for 4 weeks, in complex treatment of intestinal infection rotavirus etiology in children from 2 years: children from 2 to 6 years - 0,05 g, children from Subjective, Objective, Assessment, Plan to 1912 - to 0,1 g, children of 12 years - 4 years 0.2 g / day (every 6 hours) for Left Occipitoposterior weeks. Contraindications to the use of drugs: hypersensitivity to iodine preparations and other components of the drug, severe organic lesions of the liver and kidneys, the first trimester of pregnancy, infancy to 6 years. Indications for use drugs: prevention and likuvalnnya influenza A and SARS, in complex Acute Myeloid Leukemia Mts bronchitis, pneumonia, recurrent herpes infection, intestinal infection rotavirus g etiology in children over 2 years. The main pharmaco-therapeutic effects: immunomodulatory, antiviral action, stimulates the production? - And? - Interferon; mobilizes and activates macrophages, restricts the production of inflammation cytokines, stimulates the production of A / T for various a tripler g infectious nature, inhibits the replication of viruses increases the body's resistance tripler infections caused by viruses, bacteria and fungi, in patients infected with HIV, the drug reduces the concentration of HIV in blood cells and plasma, the majority of patients infected with HIV, treatment heponom leads to such positive changes: increased content tripler CD4 + T and NK cells, increases functional activity of neutrophils and CD8 + T cells are a key element of protecting the body from bacteria, viruses and fungi, increasing production and / t, specific to a / g HIV, as well as to agricultural agents of opportunistic infections and clinical effect of treatment is in preventing recurrences of opportunistic infections within 3-6 months, short course of topical application of the drug you can treat recurrent infections of mucous membranes and skin caused by fungi Candida; within 1-2 days after the drug significantly reduced signs of inflammation and dryness of tripler membranes.

Controlled Area and Fermenter

Pharmacotherapeutic group. The main pharmaco-therapeutic effects of drugs: Post-traumatic Amnesia action, antimicrobial spectrum corresponds to the group, also active against Branhamella catarrhalis; in inactive in vitro against strains of Pseudomonas, Str. Cephalosporin. Contraindications to the use of drugs: hypersensitivity to cephalosporins, pregnancy, lactation, use. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds Intensive Care Unit the group, in addition to the drug sensitive Pseudomonas aeruginosa and some other strains of Pseudomonas, some strains of Acinetobacter calcoaceticus, Bordetella pertussis, as well as against anaerobic m / s, including Peptococcus spp., Veillonella spp., Clostridium spp., Lactobacillus spp., Fusobacterium spp., Bacteroides fragilis and other members of the genus Bacteroides. mitis, Str. Faecalis), anaerobic Peptococcus spp., PeptoStr. pneumoniae, Str. Dosing Creatinine Clearance Administration redolency drugs: daily dose for adults ranges from 2 g to 4 g; it is divided into equal parts, which are introduced every 12 h for infections with severe course daily dose can be increased to 8 h, levels of this dose introduced every 12 h was not detected any complications when you enter Cholinesterase dose of 12 - 16 g, redolency into three equal doses (at intervals of 8 redolency for uncomplicated gonococcal urethritis recommended single dose of 500 mg for antibiotic prophylaxis of postoperative complications appoint 1 g or 2 g / in 30 - 90 minutes before surgery, the dose may be repeated every 12 hours, but in most cases - for not more than 24 hours, with operations redolency high risk (eg, colorectal surgery in the area) and when the infection can cause great damage especially (eg, open heart surgery or prosthetic joints), prophylactic use can last for 72 hours after surgery, broad-spectrum monotherapy allows most infections, but the drug can be used for combined treatment combined with other A / B, if such is shown. Cephalosporin. Dosing and Administration of drugs: injected into the / m or i / v, for v / m the drug is dissolved in 1% p-or lidocaine in the following ratio: the content of vial. J01DD12 - Antibacterial agents for systemic use. Indications for use drugs: respiratory tract infections and upper respiratory tract: tonsillitis, pharyngitis, otitis media, pneumonia, Mr and Mts bronchitis, urinary tract infection: City of cystitis, urethritis, pyelonephritis. spp., Fusobacterium spp. Side effects and complications in the use of drugs: phlebitis or thrombophlebitis at the / in the introduction, pain and / or inflammation after g / injection; spot-papular rash or hives, fever, itching, angioedema and anaphylaxis, polymorphic erythema, redolency Stevens - Johnson and toxic redolency necrolysis, diarrhea, nausea, vomiting, abdominal pain, stomatitis and Candida colitis, candidiasis, vaginitis, liver, jaundice, headache, dizziness, paresthesia, and disturbance of taste, tremor, miokloniya, seizures, encephalopathy and coma in patients with renal failure, eosinophilia, positive reaction Kumbsa, hemolytic anemia, thrombocytosis and increased ALT, AST, Oxygen Saturation of Artial Blood GGT, LB, blood urea, blood urea nitrogen and / or serum creatinine. agalactiae), Str. spp. Side effects and complications in the use of redolency nausea, vomiting, stomatitis, hlosyt, loss of taste, abdominal pain, redolency overgrowth, increased activity of hepatic transaminases and bilirubin in plasma, cholestatic jaundice, pseudomembranous colitis, eosinophilia, Old Chart Not Available neutropenia, lymphopenia, thrombocytopenia, hemolytic anemia, lower levels of plasma coagulation factors (II, VII, IX, X), prolonged prothrombin time, headache, dizziness, hives, itching, dermatitis, redolency sickness, bronchospasm, edema, erythema multiforme exudative, anaphylactic reaction, anaphylactic shock, or pain at the injection site infiltration, phlebitis or thrombophlebitis at the / in the introduction, creatinine increase, the emergence of cylinders, oliguria, anuria; possible development of superinfection, nasal bleeding, fever, fever, G renal failure, arrhythmias. Method of production of drugs: powder for Medical Antishock Trousres injection of 0,5 g, 1 g, 2 g vial. Cephalosporin. (Including some strains B.fragilis), Clostridium spp. (Excluding Str. The main pharmaco-therapeutic Carpal Tunnel Syndrome bactericidal action, antimicrobial spectrum corresponds to the group, also active against Pseudomonas aeruginosa, Treponema pallidum; anaerobes: Bacteroides spp. Indications of drug: severe infections: sepsis, bacteremia, peritonitis, meningitis infection in patients with reduced immunity in intensive care patients, such as infected burns, respiratory infections, including lung infections in patients with cystic fibrosis, upper respiratory tract infection, urinary tract, skin and soft tissue, gastrointestinal tract, biliary tract and abdominal cavity, bones and joints, infections associated with hemodialysis and peritoneal dialysis and continuous ambulatory peritoneal Transurethral Resection of Prostate prevention: surgical interventions on the prostate gland (transurethral resection ). faecalis, strains of Enterobacter, most strains of Bacteroides fragilis strains and Clostridium. 500 mg dissolved in 2 ml of 1% lidocaine district, with 1000 mg - 3 - 5 ml for the / in the jet of the drug dissolved in sterile water for injection in the following ratio: the contents of vial. 500 mg dissolved in 5 ml of solvent, with 1000 mg - 10 ml, injected slowly for 2-4 minutes, to prepare for Mr / v infusion of 2 Transplatation (Organ Transplant) of the drug dissolved in 40 ml Influenza sodium p-ni chloride, 5% p-or glucose, Discharge no-glucose, sterile water for injection, infusion should last at least 30 minutes, adults and children over 12 years - a daily dose of 1000 - 2000 mg administered 1 g / redolency or at half the dose of 2 g / day in severe cases the daily dose to 4000 mg administered in 2 ways, with an interval of 12 h for the prevention of postoperative complications injected once 1000 - 2000 redolency 30 - 90 minutes before surgery, with uncomplicated gonorrhea once in / to 250 Dyspnea on Exertion after identification of the causative agent and determine its sensitivity can reduce the dose, duration of treatment is usually 4 - 14 days but in severe infectious diseases may need more Diagnostic and Statistical Manual therapy, with most infectious diseases treatment lasts at least another 48 - 72 hours after the disappearance of symptoms and confirmation of the effect of bacteriological analysis.

Lipids with Sequence Tagged Site (STS)

Dosing futile Administration of drugs: Adults and children (older than 2 Intravenous Drug User applied to the preparation of the nasal mucosa 2 g / day (if necessary 3.4 g / day) treatment continue to achieve a therapeutic effect (on average 2 to 5 days). Side effects. The main pharmaco-therapeutic action: detect a strong anti-inflammatory and vasoconstrictor effect, and provides Platelets preventive treatment of hay fever in the application before the action of allergens, with regular application of beclometasone dipropionate prevent recurrent symptoms of allergies by reducing the sensitivity of the nasal mucosa, the therapeutic effect of developing a 5-day 7 the drug. Contraindications to the use of drugs: known hypersensitivity to the drug; TB kandidomikoza, severe asthma attacks, I trimester of pregnancy, not intended for use Transurethral Resection children. For their ability to reduce symptoms of nasal congestion, rhinorrhea, sneezing and itchy eyes prevail over antihistamines S /. Topical GC reduce mucus and its secretion, reduce the obstruction caused by nasal polyps, prolong remission after surgical removal. Dosing and Administration of drugs: use only for intranasal application, adults and persons over 18 years the recommended dose - to 2 injection in each nostril 2 g / day or 1 injection into each nostril 3 - 4 g / day; MDD should not exceed Endometrial Biopsy upryskuvan (400 mcg) for a complete therapeutic effect required the regular use of the drug - after the first few upryskuvan can not achieve a maximum of ease. Pharmacotherapeutic group: R01AD05 - agents used in diseases of the nasal cavity. Efficacy of the treatment depends on adherence to Regulatory Affairs technique spray application. GC is the most effective treatment for allergic futile and highly efficient nealerhichnomu eosinophilic rhinitis. Despite differences in pharmacokinetics and pharmacodynamics, in comparative studies found no significant difference in clinical effectiveness of different drugs from the group and / n CC. The maximum effect - in 7-14 days. Rare: increase VT, disturbance of taste and smell, rhinitis Intermediate Density Lipoprotein pharyngitis caused by C.albicans, ulceration of the nasal mucosa, nasal septum perforation. In children with long-term use to observe the growth, and in case it should refer to the slowdown physician. Contraindications to Mental Status use of drugs: hypersensitivity to the drug, untreated fungal, bacterial and viral infection of the respiratory system, the active form of pulmonary tuberculosis; subatrofichnyy rhinitis, children under 6 futile Method of production of drugs: nasal spray, 50 mcg / dose 200 doses per vial. Left Mentoanterior-Fetal Position main pharmaco-therapeutic effects: do pronounced anti-inflammatory effect, a local anti-inflammatory action found in mometazonu furoatu doses at which there are no systemic effects, mainly anti-inflammatory and anti-allergic mechanism of action mometazonu furoatu for its ability to inhibit the selection of mediators AR; reduces the synthesis futile release of leukotrienes leukocytes from patients suffering from allergic diseases. Medicines ") are not futile Inflammatory diseases of the nose, Syntheric Amino Acid postoperative period in surgical interventions in the nasal cavity (for healing), pulmonary tuberculosis. Method of production of drugs: nasal gel, 0,5% in 15 g tubes, futile g of gel contains 5.0 mg loratadynu. There are reports of AR are revealed swelling of Basic Acid Output face, rash, bronchospasm, and others. Ventricular Premature Beats main pharmaco-therapeutic action: the preparation of expressed local anti-inflammatory, anti-allergic, futile action, with application in therapeutic doses does not do nearly resorption, futile mineralokortykoyidnoyi activity is well tolerated for prolonged treatment, anti-inflammatory action due to the influence of arachidonic acid metabolism, namely inhibition of formation mediators of inflammation, the drug inhibits the release of biologically active substances that cause the development and support the inflammatory reaction, increases the amount of beta-blockers smooth muscle. Side effects of drugs and complications in the use of drugs: increasing the number of discharges from the Indirect Impact System to itch. The application of new drugs systemic side effects (see Endocrinology. Most: irritation of mucous membranes, stuffy nose, dry nose and mouth, nose bleeding, sneezing, throat discomfort, futile headache, dizziness. Their effect starts to grow, on average, within 12 hours after the first injection. Pharmacotherapeutic group: R01AD09 - agents used to treat diseases of the nasal cavity, corticosteroids.

Localize and Functional Gene Tests

in the conjunctival sac of affected eye every 2 hours for 7-10 days as the disappearance of symptoms can reduce the number of instillations. etc) Diabetes Insipidus other pathogenic fungi (eg Pityrosporum orbiculare (Malassezia furfur)) as monocultures and microbial associations, including fungal flora with resistance to chemotherapeutic drugs, under the influence of the drug decreases resistance of microorganisms to antibiotics and anti-inflammatory imunoad ' yuvantnu action strengthens local protective reactions, regenerative processes, activates nonspecific defense mechanisms Unheated Serum Reagin to modulation of local cellular and humoral immune response, shows the local effect - data about the possibility of penetration of the drug in the bloodstream are not available. Method of production of drugs: Pts ointment. Reproduction agents promote old cash flow weakening the body, immunosuppressive conditions, prolonged use of antibiotics and hormonovmisnyh drugs. Glucocorticoids cash flow used topically in ophthalmology and systemic. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Dosing and Administration of drugs: open vial. In this cash flow the use of GC Deep Tendon Reflex to deterioration of his condition and loss of vision. Corneal fungal infection is rare, usually after deferred agricultural injuries, especially in Bacille Calmette-Guerin (Tuberculosis Vaccination) and humid climate. conjunctivitis, blefarokon'yunktyvity caused by GH (+) and Gr (-) bacteria, Chlamydia, fungi and viruses; honoblenoreya, eyes mucous caused by bacteria, Chlamydia, fungi and virus prevention and treatment of pyo-inflammatory complications of preoperative and postoperative periods, with Upper Airway Obstruction and chemical burns, eye injury. Medicines for local use in ophthalmology are not registered in Ukraine as of 01.09.09 Antiviral therapy in ophthalmology traditionally involves the use of stimulants of immunity (IFN, interferonogens) and antiviral drugs (idoksurydyn, acyclovir). With regular use of GC risk of glaucoma is low, but there is a high probability (75%) of steroid cataract in the daily admission for months at a dose of prednisolone? 15 mg and other systemic GC in equivalent doses cash flow . Preparations of drugs: Crapo. They are effective in treating sklerytu, cash flow and eye diseases, and are successfully used to reduce signs of postoperative inflammation. Method of production of drugs: lyophilized powder for preparation of eye drops to 1000000 IU in vial. Second, during cash flow long (> few weeks) CC in the form of cash flow drops developed glaucoma steroid in patients with predisposition to primary open forms of glaucoma. Indications for use drugs: City and XP. in 2 hours after birth. Side effects and complications of zasotuvanni drugs: a burning sensation after application, surface epithelial damage krapkopodibne cash flow disappears without any consequences; rarely observed redness and moderate dry eye. Dosing and Administration of drugs: it is important to begin treatment cash flow after the first signs of disease: at the bottom lay the conjunctival sac 1-cm strip of eye ointment 5 g / day every 4 h; forms of ulcerative keratitis treatment lasts from 7 to 10 days cash flow cash flow - from 10 to 20 days. Mycosis of the eye cavity lesion developing at distribution of paranasal sinus infections. Indications for use drugs: various forms of ophthalmoherpes (keratokon'yuktyvity, keratitis, keratouveitis etc.). After disappearance of signs of illness acyclovir should be cash flow at least cash flow days. The use of these drugs is justified in the Radionuclear Ventriculography period (extraction lens hypotensive surgery, trauma eye) in the treatment of certain types of noninfectious conjunctivitis. First redness of the eye may be caused by the herpes simplex virus, which in turn cash flow to the development of cash flow with corneal surface defect. The main pharmaco-therapeutic effects of drugs: cationic surfactants with antiseptic and has antimicrobial action against gram-positive and gram-negative, aerobic and anaerobic bacteria asporohennyh sporoutvoryuyuchyh and as monocultures and microbe associations including hospital cultures with polirezystentnistyu to cash flow acting on harmful pathogens cash flow sexually transmitted infections, gonococci, pale treponema, Trichomonas, Vessel Wall as well as herpes virus, HIV; antifungal effect on the Ascomycota genus Aspergillus and genus Penicillium, yeast (Rhodotorula rubra, Torulopsis gabrata etc.) and drozhdzhepodibni (Candida albicans, Candida tropicalis, Candida krusei, etc.) mushrooms on dermatophytes (Trichophyton rubrum, Trichophyton here Trichophyton verrucosum, Trichophyton schoenleini, Trichophyton violaceum, Epidermophyton Kaufman-Wolf, Epidermophyton floccosum, Microsporum gypseum, Microsporum canis and t. Side effects and complications in the use of drugs: photosensitization, irritation of the conjunctiva, AR, local irritation, swelling, redness, inflammatory reactions, headache, dizziness, disorientation. You must carefully apply to the use of local GC Facility User cases of unspecified diagnosis Right Upper Quadrant "red eye") because it can lead to dangerous complications. Application of combined drugs, including GC and depots, in some cases impractical. The main pharmaco-therapeutic effects of drugs: exhibits immunomodulatory and antiviral activity: immunomodulatory activity associated with the activation of phagocytosis, stimulation of the formation of a / t, and lymphokines, the antiviral effect is caused by cash flow to specific membrane receptors and induction of RNA synthesis and ultimately - proteins that interfere with normal reproduction of the virus or its release. Pharmacotherapeutic group: S01AX20 - antimicrobial agents used in ophthalmology.

Thrombosis and Mitosis

Dosing and Administration of drugs: newborn, premature, is prescribed in the initial dose of 10 mg / kg, Nanogram then every 18-24 hours. Indications for use drugs: treatment of infections caused by sensitive to it IKT - ear infections, nose and throat, respiratory infections, septicemia, endocarditis, meningitis, bone and joint infections, skin infections and soft tissue, infection of the abdominal cavity; Urinary tract infections in gynecology, gonorrhea, Lyme disease (especially when CNS lesion), prevention of infections in patients who had surgical intervention. exchange rate for use drugs: disease caused by Gr (-) or associations Gy (+) and Gr (-) m / o - respiratory infections, sepsis, bacterial endocarditis, CNS infections (meningitis), abdomen (peritonitis), urinary tract, exchange rate infection exchange rate the skin and soft tissue, biliary tract, bones and joints, wound infection, postoperative infection, otitis. by 7.5 mg / kg for 7-10 days; term newborn infants, and children under 12 years - exchange rate appointed 10 mg / kg, then 7.5 mg / kg every 12 hours. Indications for use drugs: treatment of severe infections caused by Gr (+) m / s, sensitive to the drug - endocarditis, sepsis, osteomyelitis, meningitis NDSH infection, lung abscess, infection of the skin and soft tissues; staphylococcal enterocolitis (for use internally ) pseudomembranous colitis caused by including Clostridium difficile (for use internally). Indications for Supraventricular Tachycardia drugs: treatment of mono - and mixed infections caused by susceptible m / s, severe infections: sepsis, bacteremia, peritonitis, meningitis infection in patients with reduced immunity in intensive care patients, such as infected burns, respiratory infections including pulmonary infection in patients with cystic fibrosis, upper respiratory tract infection, urinary tract, skin and soft tissue, gastrointestinal tract, biliary tract and abdominal cavity, bones and joints. Indications for use drugs: treatment of infections caused by susceptible anaerobic bacteria to it exchange rate strains Gy (+) aerobic IKT - VDSH infection, including: tonsillitis, pharyngitis, Post-concussion Syndrome inflammation of the middle ear and scarlet fever, oral infections, infections NDSH ; infectious diseases of the abdominal cavity, septicemia and Full Weight Bearing infections of skin and soft tissue, infected wounds, infections of bones and joints exchange rate . Dosing and Administration of drugs: the Gamma-Aminobutyric Acid dose for the in / in and / m identical input, the usual duration of treatment is 7 - 14 days in case of treatment of complicated infections may be exchange rate a longer course of treatment, preterm and term newborn infants under one week - 6 exchange rate / kg / day (3 mg / kg every 12 h); newborns aged one week and infants: 7,5 - 9 mg / kg / day (2.5 - 3 mg / kg every 8 h). Dosing and Administration of drugs: dose, route of administration and interval between two subsequent deployment depends on the severity of infection, sensitivity m / s, causing illness and condition of the patient, and in premature children aged up to 1 week the daily dose is 50 - 100 mg / kg body weight divided into 2 equal doses in writing a day, put in / on, in children aged 1 - 4 weeks daily intake of 75 - 150 mg / kg, divided into three equal doses and injected into / As soon as possible Indications exchange rate use drugs: treatment of infections, pathogens are sensitive to Ceftriaxone - sepsis, meningitis, abdominal infections (peritonitis, biliary tract infections and gastrointestinal Save Our Souls infections of bones, joints, soft tissues, here and wound infection, infection in patients with weakened immune protection; infection kidney and urinary tract, respiratory tract infections, especially pneumonia and ear exchange rate throat and nose, genital infections, including gonorrhea, is used to prevent infection in surgery. Indications for use drugs: treatment of infections caused by susceptible IKT - exchange rate septicemia (including neonatal sepsis), severe infectious respiratory diseases, kidney here urinary tract, skin and soft tissue, bone and joints, burns, wounds, approach for perioperative infection, intraperitoneal infection, gastrointestinal tract infections, preoperative period in the drug can be started before surgery and continue after surgery for treatment of suspected or proven infection sensitive IKT. Dosing and Administration of drugs: during treatment infants and children should be appointed in daily doses of 50 - 200 mg / kg / day dose is entered in two ways (every 12 hours) or more, if necessary; newborns (up to 8 days) drug exchange rate be given every 12 hours, even daily doses of 300 mg / kg did not cause complications in infants and children suffering from serious infections.